Valentín Cabanas-Perianes

20PUBLICATIONS
177CO-AUTHORS
Innate immunityPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Nov 09, 2025
Shared Decision-Making in Treatment Selection in Multiple Myeloma in Spain: The PRISMMA Study.

Valentín Cabañas, María Casanova, Begoña Barragán

|Jul 11, 2025
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma.

Mireia Uribe-Herranz, Aina Oliver-Caldés, Neus Martínez-Micaelo

|Jun 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.

Juan José Lahuerta, Jesús San-Miguel, Ana Jiménez-Ubieto

|Apr 15, 2025
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.

Camila Guerrero, Maria-Jose Larrayoz, Irache Erdozain

|Apr 02, 2025
Intestinal Perforation Secondary to Bortezomib-Induced Autonomic Neuropathy.

Jose Antonio Sánchez Salas, Maria Jose Moreno Belmonte, Andrea Poveda García

Pageof 4